Medical Devices and IVDs April 01, 2026

Common Reasons for MFDS Medical Device Application Rejections

OMC Admin

OMC AdminContent Writer

Common Reasons for MFDS Medical Device Application Rejections

Common Reasons for MFDS Medical Device Application Rejections  

Entering the South Korean medical device market regulated by the Ministry of Food and Drug Safety (MFDS) offers significant growth opportunities for global manufacturers. However, one of the biggest challenges companies face is application rejection or unexpected approval delays. 

Even well-prepared submissions can face setbacks due to regulatory nuances, local requirements, and documentation gaps. Understanding these pitfalls is critical to ensuring a smooth and successful approval process. 

In this article, we explore the most common reasons for MFDS medical device application rejection and provide actionable insights to help you avoid them. 

8 most common reasons for MFDS medical device application rejection 

1. Incorrect Product Classification 

One of the most frequent causes of rejection is incorrect classification of the medical device. 

Why this happens: 

  • Misalignment with Korean classification rules  

  • Assuming EU MDR or US FDA classification applies  

  • Lack of product code validation  

Impact: 

  • Wrong regulatory pathway  

  • Missing required documentation  

  • Immediate rejection or re-submission  

How to avoid: 

  • Conduct Korea-specific classification analysis  

  • Verify MFDS product codes  

  • Consult regulatory experts early  

2. Incomplete Technical Documentation 

MFDS requires detailed and structured technical documentation. 

Common issues: 

  • Missing device description  

  • Incomplete risk management files  

  • Lack of performance testing data  

Impact: 

  • Deficiency letters  

  • Multiple review cycles  

  • Approval delays  

How to avoid: 

  • Follow STED or MFDS format  

  • Ensure complete documentation  

  • Translate all documents into Korean  

3. Insufficient Clinical Evidence 

Clinical evidence is crucial, especially for high-risk devices. 

Common gaps: 

  • Weak Clinical Evaluation Reports (CER)  

  • Inadequate justification for foreign data  

MFDS expectations: 

  • Local clinical trials (if required)  

  • Strong safety and performance data  

  • Proper equivalence demonstration  

How to avoid: 

  • Plan clinical strategy early  

  • Align with Korean GCP  

  • Strengthen clinical justification  

4. KGMP Certification Issues 

Korean Good Manufacturing Practice (KGMP) compliance is mandatory. 

Common problems: 

  • Failed audits  

  • Incomplete QMS documentation  

  • Poor alignment with ISO standards  

Impact: 

  • Approval cannot proceed  

  • Re-audits and delays  

How to avoid: 

  • Conduct internal audits  

  • Prepare thoroughly before inspection  

5. Submission Format Errors 

Simple mistakes can lead to rejection. 

Common errors: 

  • Incorrect formats  

  • Missing signatures  

  • Inconsistent data  

  • Wrong forms  

Impact: 

  • Administrative rejection  

  • Restart of submission process  

How to avoid: 

  • Follow MFDS templates strictly  

  • Perform final compliance checks  

6. Labeling and IFU Non-Compliance 

Labeling is often overlooked but critical. 

Issues: 

  • Not translated into Korean  

  • Missing symbols  

  • Inconsistencies  

Impact: 

  • Immediate deficiency notice  

Solution: 

  • Ensure full Korean compliance  

  • Align with submitted documentation  

7. Lack of a Qualified Korea License Holder (KLH) 

A local representative is mandatory. 

Common mistakes: 

  • Choosing inexperienced KLH  

  • Poor communication  

Impact: 

  • Misfiled submissions  

  • Delays  

Solution: 

  • Work with experienced KLH  

  • Maintain strong coordination  

8. Poor Response to MFDS Queries 

Issues: 

  • Delayed responses  

  • Incomplete answers  

Impact: 

  • Review delays  

  • Additional queries  

Solution: 

  • Respond quickly and clearly  

  • Provide structured responses  

Key Takeaways 

To avoid MFDS medical device application rejection: 

  • Ensure correct classification  

  • Prepare complete documentation  

  • Provide strong clinical data  

  • Achieve KGMP compliance  

  • Avoid submission errors  

  • Ensure labeling compliance  

  • Appoint qualified KLH  

  • Respond promptly to MFDS 

How OMC Medical Can Help 

Navigating the regulatory framework of the Ministry of Food and Drug Safety (MFDS) can be complex, especially for foreign manufacturers unfamiliar with Korean-specific requirements. At OMC Medical, we specialize in helping companies eliminate the risk of MFDS medical device application rejection and achieve faster, smoother approvals. 

End-to-End MFDS Regulatory Support 

We provide complete, start-to-finish support throughout your South Korea market entry journey: 

  • Regulatory pathway identification  

  • Product classification as per MFDS codes  

  • Documentation planning and submission strategy  

  • Direct coordination with MFDS authorities  

Our structured approach ensures your application is accurate, compliant, and submission-ready from day one. 

Accurate Product Classification & Strategy 

Incorrect classification is one of the top reasons for rejection. Our experts: 

  • Analyze your device against Korean classification guidelines  

  • Map your product to the correct MFDS product code  

  • Define the most efficient approval pathway  

This prevents costly rejections and re-submissions. 

Technical Documentation Preparation & Review 

We help you build complete, audit-ready technical documentation aligned with MFDS expectations: 

  • Device description and intended use  

  • Risk management files (ISO 14971 aligned)  

  • Performance and safety testing data  

  • Labeling and IFU compliance  

  • STED/Technical File structuring  

Our team performs multi-level quality checks to eliminate gaps that typically lead to deficiency letters. 

Clinical Data & Evaluation Support 

For medium and high-risk devices, strong clinical evidence is essential. OMC Medical supports: 

  • Clinical Evaluation Report (CER) preparation  

  • Gap analysis of existing clinical data  

  • Strategy for leveraging foreign clinical data  

  • Guidance on local clinical trial requirements  

We ensure your clinical documentation meets MFDS expectations for safety and performance. 

KGMP Audit Readiness 

Korean Good Manufacturing Practice (KGMP) compliance is mandatory—and often a bottleneck. 

We help you: 

  • Align your QMS with ISO 13485 and KGMP requirements  

  • Conduct pre-audit assessments  

  • Identify and close compliance gaps  

  • Prepare for successful KGMP inspections  

This significantly reduces the risk of audit failure and approval delays. 

Korea License Holder (KLH) Services 

Foreign manufacturers must appoint a Korea License Holder (KLH) to interact with MFDS. 

OMC Medical provides: 

  • Reliable KLH representation  

  • Regulatory communication with MFDS  

  • Submission management and follow-ups  

With our experienced KLH team, you avoid miscommunication, delays, and compliance risks. 

Submission & Compliance Checks 

Before submission, we conduct comprehensive validation checks: 

  • Format and template compliance  

  • Document consistency across all files  

  • Verification of signatures, translations, and labeling  

  • Final submission readiness review  

This ensures your application is fully compliant and error-free, reducing the chances of rejection. 

 

Fast & Effective MFDS Query Management 

MFDS often raises queries during the review process. Our team ensures: 

  • Rapid response to deficiency letters  

  • Clear, structured, and evidence-based replies  

  • Continuous follow-up with authorities  

This helps avoid delays and keeps your approval timeline on track. 

Why Choose OMC Medical? 

  • End-to-end support from strategy to approval  

  • Strong focus on first-time approval success  

  • Dedicated regulatory experts and KLH services  

  • Global experience across multiple regulatory markets  

Accelerate Your MFDS Approval with Confidence 

At OMC Medical, we don’t just support your application—we optimize it for success. Our goal is to help you: 

  • Minimize rejection risks  

  • Reduce approval timelines  

  • Achieve faster market entry in South Korea  

👉 Partner with OMC Medical to navigate MFDS requirements with confidence and precision. 

Final Thoughts 

MFDS rejections are not random—they are usually due to avoidable mistakes. With proper planning, expert guidance, and complete documentation, manufacturers can significantly reduce approval timelines and successfully enter the Korean market. 

Enjoyed this article?

Share it with your network and help others discover great content.

Related Blogs

Stay updated with the latest regulatory updates and insights

How Regulatory Harmonization Could Speed Up Medical Device Approvals by 2026

November 13, 2025

How Regulatory Harmonization Could Speed Up Medical Device Approvals by 2026
Learn More
MDCG Guidance for Manufacturers of Class I Medical Devices

October 15, 2025

MDCG Guidance for Manufacturers of Class I Medical Devices
Learn More
How to Register Medical Devices in the Saudi Market?

October 16, 2025

How to Register Medical Devices in the Saudi Market?
Learn More
LinkedIn Message on LinkedIn WhatsApp Start WhatsApp chat Call Call us